Premium Nahrungsergänzungsmittel | artgerecht

Hepatitis B Surface Antigen (HBsAg) – Overview

The hepatitis B surface antigen (HBsAg) is a protein found on the outer coat of the hepatitis B virus and the primary blood marker used to diagnose a hepatitis B infection.

Regular tips about health Regular tips about health

Things worth knowing about "Hepatitis B Surface Antigen"

The hepatitis B surface antigen (HBsAg) is a protein found on the outer coat of the hepatitis B virus and the primary blood marker used to diagnose a hepatitis B infection.

What Is the Hepatitis B Surface Antigen?

The hepatitis B surface antigen (abbreviated HBsAg) is a protein located on the outer envelope of the hepatitis B virus (HBV). It is produced by the virus in large quantities and released into the bloodstream. In clinical practice, the detection of HBsAg in blood is the most important and reliable marker for identifying an active acute or chronic hepatitis B infection.

Clinical Significance

The HBsAg test is a fundamental component of hepatitis B diagnostics. A positive result indicates that a person is currently infected with the hepatitis B virus and may be able to transmit it to others. Two key scenarios are distinguished:

Acute hepatitis B: HBsAg typically becomes detectable within 1 to 10 weeks after infection. In people who successfully clear the virus, HBsAg disappears within six months.
Chronic hepatitis B: If HBsAg remains detectable for more than six months, the infection is classified as chronic. An estimated 296 million people worldwide are living with chronic hepatitis B.

Diagnosis

HBsAg is detected through a serological blood test, in which a blood sample is analyzed for the presence of the antigen. In clinical practice, the HBsAg test is typically combined with other serological markers to fully characterize the stage and activity of the infection:

Anti-HBs: Antibodies against HBsAg indicating recovery from infection or successful vaccination.
Anti-HBc (IgM and IgG): Antibodies against the hepatitis B core antigen, detectable during acute or past infection.
HBeAg and anti-HBe: Additional markers providing information about viral activity and infectivity.
HBV DNA: Quantitative measurement of viral load, used primarily to monitor antiviral therapy.

Causes of Hepatitis B Infection

The hepatitis B virus is transmitted through contact with infected blood or other bodily fluids. Common routes of transmission include:

Unprotected sexual contact with an infected person
Sharing needles or syringes, particularly in the context of intravenous drug use
Mother-to-child transmission during childbirth (perinatal transmission)
Exposure to contaminated blood through medical procedures or injuries

Symptoms of Hepatitis B

Many people infected with hepatitis B experience no symptoms or only mild ones, especially in the early stages. When symptoms do occur, they may include:

Yellowing of the skin and whites of the eyes (jaundice)
Fatigue and general weakness
Nausea, vomiting, and loss of appetite
Dark urine and pale stools
Pain or discomfort in the upper right abdomen
Joint pain

Treatment

Treatment of hepatitis B depends on the stage of the disease:

Acute hepatitis B: In most adults, the immune system clears the infection without specific antiviral treatment. Management is supportive, focusing on rest, adequate hydration, and avoiding substances that stress the liver, such as alcohol.
Chronic hepatitis B: Antiviral therapy is used to suppress viral replication and prevent disease progression. First-line treatments include nucleos(t)ide analogues such as tenofovir and entecavir, as well as pegylated interferon alfa. These therapies reduce the risk of serious complications such as liver cirrhosis and hepatocellular carcinoma.

Prevention and Vaccination

The most effective way to prevent hepatitis B infection is through vaccination. The hepatitis B vaccine is highly effective and is recommended for all infants as well as high-risk groups. Successful vaccination leads to the formation of anti-HBs antibodies that provide long-term protection. Additional preventive measures include using condoms, avoiding shared needles, and maintaining proper hygiene standards in healthcare settings.

References

World Health Organization (WHO): Hepatitis B Fact Sheet. Geneva, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
European Association for the Study of the Liver (EASL): Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology, 2017;67(2):370-398.
Terrault NA et al.: AASLD guidelines for treatment of chronic hepatitis B. Hepatology, 2018;67(4):1560-1599.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.